Clinical trials
Phase 2/3 Dermatomyositis trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
8 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2011 | 1 |
| 2015 | 1 |
| 2017 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 3 |
| Terminated | 3 |
| Recruiting | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Alexion Pharmaceuticals, Inc. | 1 |
| Cabaletta Bio | 1 |
| Children's Hospital Medical Center, Cincinnati | 1 |
| National Institute of Environmental Health Sciences (NIEHS) | 1 |
| Northwell Health | 1 |
| Restem, LLC. | 1 |
| University of Michigan | 1 |
| argenx | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Dermatomyositis | 8 |
| Myositis | 5 |
| Polymyositis | 3 |
| Arthritis, Rheumatoid | 1 |
| Autoimmune Diseases | 1 |
| Calcinosis | 1 |
| Connective Tissue Diseases | 1 |
| Lung Diseases, Interstitial | 1 |
| Mixed Connective Tissue Disease | 1 |
| Myalgia | 1 |
Trials
Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.